TD Asset Management »

Belite Bio shares owned by TD Asset Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.3M 33k 159.44

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Cibc Cad (CM)
Broadcom (AVGO)
Agnico (AEM)
Canadian Natural Resources (CNQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Suncor Energy (SU)
Amazon (AMZN)

View all positions for TD Asset Management

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio